Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial-Reference-Cited by-同舟云学术

Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial

Published:2015-07 Issue:7 Volume:16 Page:763-774
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Thatcher Nick,Hirsch Fred R,Luft Alexander V,Szczesna Aleksandra,Ciuleanu Tudor E,Dediu Mircea,Ramlau Rodryg,Galiulin Rinat K,Bálint Beatrix,Losonczy György,Kazarnowicz Andrzej,Park Keunchil,Schumann Christian,Reck Martin,Depenbrock Henrik,Nanda Shivani,Kruljac-Letunic Anamarija,Kurek Raffael,Paz-Ares Luis,Socinski Mark A

Publisher

Elsevier BV

Subject

Oncology

Reference43 articles.

1. Squamous cell carcinoma of the lung: molecular subtypes and therapeutic opportunities;Perez-Moreno;Clin Cancer Res,2012

2. Non-small-cell lung cancers: a heterogeneous set of diseases;Chen;Nat Rev Cancer,2014

3. Squamous cell lung cancer: from tumor genomics to cancer therapeutics;Gandara;Clin Cancer Res,2015

4. 2nd ESMO Consensus Conference on Lung Cancer: non-small-cell lung cancer first-line/second and further lines of treatment in advanced disease;Besse;Ann Oncol,2014

5. Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer;Sandler;N Engl J Med,2006

Cited by 427 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phage display for discovery of anticancer antibodies;New Biotechnology;2024-11

2. Magnetic Miniature Soft Robot with Reprogrammable Drug‐Dispensing Functionalities: Toward Advanced Targeted Combination Therapy;Advanced Materials;2024-09-09

3. Rediscovering immunohistochemistry in lung cancer;Critical Reviews in Oncology/Hematology;2024-08

4. Incorporation of immunotherapies and nanomedicine to better normalize angiogenesis-based cancer treatment;Microvascular Research;2024-07

5. Phage Display Technology in Biomarker Identification with Emphasis on Non-Cancerous Diseases;Molecules;2024-06-25